FDA Convenes Panel To Review Drug-Associated Suicidality Study
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA joint committee meets July 10 to consider results of placebo-controlled trials of 11 drugs, including Lamictal, Carbatrol and Lyrica.